A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu et al., Cancer Statistics, 2006, Cancer statistics, pp.106-130, 2006.
DOI : 10.3322/canjclin.56.2.106

D. Parkin, P. Pisani, and J. Ferlay, Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.49, issue.1, pp.33-64, 1999.
DOI : 10.3322/canjclin.49.1.33

P. Lauren, The two histological main types of gastric carcinoma: diffuse and socalledintestinal-type. An attempt at a histo-clinical classification, Acta Pathol Microbiol Scand, vol.64, pp.31-49, 1965.

C. Fenoglio-preiser, N. Muñoz, F. Carneiro, S. Powell, P. Correa et al., Gastric carcinoma, Pathology and Genetics of Tumours of the Digestive System of Tumors. Edited by Hamilton SR, pp.35-50, 2000.

H. Wu, J. Rusiecki, K. Zhu, J. Potter, and S. Devesa, Stomach Carcinoma Incidence Patterns in the United States by Histologic Type and Anatomic Site, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.7, pp.1945-1952, 2009.
DOI : 10.1158/1055-9965.EPI-09-0250

D. Henson, C. Dittus, M. Younes, H. Nguyen, and J. Albores-saavedra, Differential trends in the intestinal and diffuse types of gastric carcinoma in th United States: increase in the signet ring cell type, Arch Pathol Lab Med, vol.128, pp.765-770, 1973.

G. Baiocchi, G. Tiberio, A. Minicozzi, P. Morgagni, D. Marrelli et al., A Multicentric Western Analysis of Prognostic Factors in Advanced, Node-Negative Gastric Cancer Patients, Annals of Surgery, vol.252, issue.1, pp.70-73, 2010.
DOI : 10.1097/SLA.0b013e3181e4585e

M. Messager, J. Lefevre, V. Pichot-delahaye, A. Souadka, G. Piessen et al., The Impact of Perioperative Chemotherapy on Survival in Patients With Gastric Signet Ring Cell Adenocarcinoma, Annals of Surgery, vol.254, issue.5, pp.684-693, 2011.
DOI : 10.1097/SLA.0b013e3182352647

D. Cunningham, W. Allum, S. Stenning, J. Thompson, C. Van-de-velde et al., Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer, New England Journal of Medicine, vol.355, issue.1, pp.11-20, 2006.
DOI : 10.1056/NEJMoa055531

M. Ychou, V. Boige, J. Pignon, T. Conroy, O. Bouche et al., Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial, Journal of Clinical Oncology, vol.29, issue.13, pp.1715-1721, 2011.
DOI : 10.1200/JCO.2010.33.0597

URL : https://hal.archives-ouvertes.fr/hal-00596037

P. Rougier, M. Ducreux, M. Mahjoubi, J. Pignon, S. Bellefgih et al., Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis, European Journal of Cancer, vol.30, issue.9, pp.1263-1269, 1994.
DOI : 10.1016/0959-8049(94)90170-8

G. Piessen, M. Messager, E. Leteurtre, J. Triboulet, and C. Mariette, Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical Presentation, Annals of Surgery, vol.250, issue.6, pp.878-887, 2009.
DOI : 10.1097/SLA.0b013e3181b21c7b

H. Takiuchi, I. Hirata, S. Kawabe, Y. Egashira, and K. Katsu, Immunohistochemical expression of vascular endothelial growth factor can predict response to 5-fluorouracil and cisplatin in patients with gastric adenocarcinoma., Oncology Reports, vol.7, pp.841-846, 2000.
DOI : 10.3892/or.7.4.841

K. Ott, K. Herrmann, F. Lordick, H. Wieder, W. Weber et al., Early Metabolic Response Evaluation by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Allows In vivo Testing of Chemosensitivity in Gastric Cancer: Long-term Results of a Prospective Study, Clinical Cancer Research, vol.14, issue.7, pp.2012-2018, 2008.
DOI : 10.1158/1078-0432.CCR-07-0934

G. Piessen, D. Amielh, M. Messager, E. Vinatier, E. Leteurtre et al., Is Pretreatment Endoscopic Biopsy a Good Predictor of Signet Ring Cell Histology in Gastric Carcinoma?, World Journal of Surgery, vol.33, issue.Suppl, pp.346-354, 2012.
DOI : 10.1007/s00268-011-1351-9

D. Dindo, N. Demartines, and P. Clavien, Classification of Surgical Complications, Annals of Surgery, vol.240, issue.2, pp.205-213, 2004.
DOI : 10.1097/01.sla.0000133083.54934.ae

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1360123

K. Slim, J. Blay, A. Brouquet, D. Chatelain, M. Comy et al., Digestive oncology: surgical practices, J Chir, vol.146, pp.11-80, 2009.

C. Mariette, A. Alves, S. Benoist, F. Bretagnol, J. Mabrut et al., Soins p??riop??ratoires en chirurgie digestive, Journal de Chirurgie, vol.142, issue.1, pp.14-28, 2005.
DOI : 10.1016/S0021-7697(05)80831-2

B. Smith and B. Stabile, Extreme Aggressiveness and Lethality of Gastric Adenocarcinoma in the Very Young, Archives of Surgery, vol.144, issue.6, pp.506-510, 2009.
DOI : 10.1001/archsurg.2009.77

. Piessen, Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas ??? PRODIGE 19 ??? FFCD1103 ??? ADCI002, BMC Cancer, vol.144, issue.1, pp.19-1103, 2013.
DOI : 10.1001/archsurg.2009.77

URL : https://hal.archives-ouvertes.fr/inserm-00839324